{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:15:14Z","timestamp":1785039314112,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nottingham University Hospitals Charity","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Plasma-Lyte is a balanced, crystalloid intravenous fluid which has been shown to avoid the hyperchloremic metabolic acidosis associated with 0.9% sodium chloride. Data on physical, pH and chemical compatibility with other medicines are essential.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The compatibility of adrenaline, dobutamine, dopamine, furosemide, midazolam, morphine and milrinone with Plasma-Lyte 148 (PLA) and Plasma-Lyte 148 with 5% glucose (PLA-G) was investigated. Control solutions were 0.9% sodium chloride and 5% glucose. Chemical stability was defined as &lt;\u20095% concentration change with high-performance liquid chromatography (HPLC). Physical compatibility was assessed by checking for colour changes and precipitate formation. The pH of the admixtures was considered acceptable if between 5 and 9 at all time points. Six repeats were carried out for HPLC, 2 for physical compatibility checks and pH measurements, with all admixtures being tested at 0, 2 and 24\u2009h after mixing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All combinations were found to be chemically stable at 0, 2 and 24\u2009h apart from furosemide with PLA-G at 24\u2009h and midazolam with PLA or PLA-G at both 2 and 24\u2009h. Only midazolam was physically incompatible when mixed with both Plasma-Lyte solutions. The pH remained stable in all admixtures, although not all pH values recorded were within the range of 5\u20139.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>All drugs excluding furosemide and midazolam were shown to be chemically, physically and pH stable at the tested concentrations when diluted with PLA and PLA-G.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40635-020-00311-5","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T11:03:07Z","timestamp":1592910187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Plasma-Lyte 148 and Plasma-Lyte 148 + 5% glucose compatibility with commonly used critical care drugs"],"prefix":"10.1186","volume":"8","author":[{"given":"Sophie","family":"Hammond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wignell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cooling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6540-6368","authenticated-orcid":false,"given":"Patrick","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"issue":"2","key":"311_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.clnu.2008.01.008","volume":"27","author":"S Awad","year":"2008","unstructured":"Awad S et al (2008) The history of 0.9% saline. Clin Nutr (Edinburgh, Scotland) 27(2):179","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"key":"311_CR2","doi-asserted-by":"crossref","unstructured":"Hahn, R.G., II. Should anaesthetists stop infusing isotonic saline? 2014, British Journal of Anaesthesia. p. 4-6.","DOI":"10.1093\/bja\/aet292"},{"issue":"5","key":"311_CR3","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/00000542-199905000-00007","volume":"90","author":"U Finsterer","year":"1999","unstructured":"Finsterer U et al (1999) Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology 90(5):1265\u20131270","journal-title":"Anesthesiology"},{"issue":"6","key":"311_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1136\/adc.83.6.514","volume":"83","author":"S Skellett","year":"2000","unstructured":"Skellett S et al (2000) Chasing the base deficit: hyperchloraemic acidosis following 0.9% saline fluid resuscitation. Arch Dis Childhood 83(6):514\u2013516","journal-title":"Arch Dis Childhood"},{"issue":"2","key":"311_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/JTN.0000000000000115","volume":"22","author":"ME Barker","year":"2015","unstructured":"Barker ME (2015) 0.9% saline induced hyperchloremic acidosis. J Trauma Nurs 22(2):111","journal-title":"J Trauma Nurs"},{"issue":"1","key":"311_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1213\/ane.0b013e3181732d64","volume":"107","author":"N Hadimioglu","year":"2008","unstructured":"Hadimioglu N et al (2008) The effect of different crystalloid solutions on acid- base balance and early kidney function after kidney transplantation. Anesth Analg 107(1):264","journal-title":"Anesth Analg"},{"key":"311_CR7","doi-asserted-by":"crossref","unstructured":"Lee, J.Y., et al., Hyperchloremia is associated with 30-day mortality in major trauma patients: a retrospective observational study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2016. 24.","DOI":"10.1186\/s13049-016-0311-7"},{"key":"311_CR8","doi-asserted-by":"crossref","unstructured":"Sen, A., et al., Chloride content of fluids used for large-volume resuscitation is associated with reduced survival. 2016, Society of Critical Care Medicine","DOI":"10.1097\/CCM.0000000000002063"},{"issue":"2","key":"311_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jcrc.2010.04.013","volume":"26","author":"MM Boniatti","year":"2011","unstructured":"Boniatti MM et al (2011) Is hyperchloremia associated with mortality in critically ill patients? A prospective cohort study. J Crit Care 26(2):175\u2013179","journal-title":"J Crit Care"},{"issue":"2","key":"311_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1213\/ANE.0b013e318293d81e","volume":"117","author":"AS McCluskey","year":"2013","unstructured":"McCluskey AS et al (2013) Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity- matched cohort study. Anesth Analg 117(2):412\u2013421","journal-title":"Anesth Analg"},{"issue":"9","key":"311_CR11","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1097\/CCM.0000000000001161","volume":"43","author":"AJ Neyra","year":"2015","unstructured":"Neyra AJ et al (2015) Association of hyperchloremia with hospital mortality in critically ill septic patients. Crit Care Med 43(9):1938\u20131944","journal-title":"Crit Care Med"},{"issue":"4","key":"311_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5492\/wjccm.v5.i4.235","volume":"5","author":"L Weinberg","year":"2016","unstructured":"Weinberg L et al (2016) Plasma-Lyte 148: a clinical review. World J Crit Care Med 5(4):235\u2013250","journal-title":"World J Crit Care Med"},{"key":"311_CR13","unstructured":"NICE . Plasma-Lyte 148 (water). 2016 14\/6\/16]; Available from: https:\/\/www.evidence.nhs.uk\/formulary\/bnf\/current\/9-nutrition-and-blood\/93-intravenous-nutrition\/proprietary-infusion-fluids-for-parenteral-feeding\/plasma-lyte-148-water."},{"key":"311_CR14","doi-asserted-by":"crossref","unstructured":"Guidet, B., et al., A balanced view of balanced solutions. Critical Care, 2010. 14(5).","DOI":"10.1186\/cc9230"},{"issue":"2","key":"311_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jcrc.2012.01.007","volume":"27","author":"H-R Chua","year":"2012","unstructured":"Chua H-R et al (2012) Plasma- Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care 27(2):138\u2013145","journal-title":"J Crit Care"},{"key":"311_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-016-0652-4","volume":"16","author":"CH Allen","year":"2016","unstructured":"Allen CH (2016) A randomized trial of plasma- Lyte a and 0.9 % sodium chloride in acute pediatric gastroenteritis. BMC Pediatr 16:1\u201310","journal-title":"BMC Pediatr"},{"issue":"5","key":"311_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/SLA.0b013e31825074f5","volume":"255","author":"AD Shaw","year":"2012","unstructured":"Shaw AD et al (2012) Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to plasma- Lyte. Ann Surg 255(5):821","journal-title":"Ann Surg"},{"issue":"2","key":"311_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/SLA.0b013e318295feba","volume":"259","author":"JB Young","year":"2014","unstructured":"Young JB et al (2014) Saline versus plasma- Lyte a in initial resuscitation of trauma patients: a randomized trial. Ann Surg 259(2):255","journal-title":"Ann Surg"},{"issue":"2","key":"311_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/ndt\/gfu005","volume":"30","author":"D Severs","year":"2015","unstructured":"Severs D et al (2015) A critical appraisal of intravenous fluids: from the physiological basis to clinical evidence. Nephrol Dialysis Transplant 30(2):178\u2013187","journal-title":"Nephrol Dialysis Transplant"},{"key":"311_CR20","unstructured":"Dawson, R., et al., Pharmaco-stability of Plasma-Lyte 148 and Plasma-Lyte 148 + 5% dextrose with commonly used therapeutic agents. In Press, Paediatric Anaesthesia, 2018"},{"key":"311_CR21","volume-title":"Y site compatibility of intravenous drugs with plasma-Lyte 148","author":"Baxter Healthcare","year":"2015","unstructured":"Baxter Healthcare (2015) Y site compatibility of intravenous drugs with plasma-Lyte 148"},{"key":"311_CR22","unstructured":"Josephson, D.L., Intravenous infusion therapy for nurses : principles & practice \/ Dianne L. Josephson. 2nd ed. ed. 2004, Clifton Park, N.Y.: Clifton Park, N.Y.: Delmar."},{"key":"311_CR23","unstructured":"NHS Pharmaceutical Quality Assurance Committee. A standard protocol for deriving and assessment of stability. 2019; Available from: https:\/\/www.sps.nhs.uk\/wp-content\/uploads\/2013\/12\/Stability-part-1-small-molecules-5th-Ed-Sept-19.pdf."},{"key":"311_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.NURSE.0000334057.91316.45","volume":"38","author":"K Rosenthal","year":"2008","unstructured":"Rosenthal K (2008) Bridging the I.V. access gap with midline catheters. Nursing 38:2\u20135","journal-title":"Nursing"},{"key":"311_CR25","unstructured":"Infusion Nurses Society, Infusion nursing standards of practice. 2011, Journal of Infusion Nursing. p. S37."},{"key":"311_CR26","unstructured":"Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. Y-set. 2003 August 1 2018]; Available from: https:\/\/medical-dictionary.thefreedictionary.com\/Y-set."}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-020-00311-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-020-00311-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-020-00311-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T01:44:51Z","timestamp":1667094291000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-020-00311-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["311"],"URL":"https:\/\/doi.org\/10.1186\/s40635-020-00311-5","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"11 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable: no human subjects","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consented","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare they have no conflicts of interest in this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}